Skip to main content
. 2003 Mar 18;88(6):940–943. doi: 10.1038/sj.bjc.6600805

Figure 2.

Figure 2

Anatomopathological studies. (A) Normal skin, (B) untreated tumour, (C) treated tumour for 4 weeks with 500 μg of LG, (D) skin after tumour regression (treatment with 500 μg of LG for 8 weeks) and (E) normal skin treated with 500 μg of LG for 8 weeks.